You are here: Industry Insights > acquisition

News List

Carlyle Group to acquire 20 per cent stake in Piramal Pharma expresspharma
June 28, 2020
The transaction worth $490 million is expected to close in 2020, subject to customary closing conditions and regulatory approvals.
Boehringer to sell stake in Hikma pharmatimes
June 24, 2020
Boehringer Ingelheim Invest has announced plans to pull its investment in Hikma Pharmaceuticals.
Apple Tree Partners Portfolio Company Corvidia Therapeutics to be Acquired by Novo Nordisk americanpharmaceuticalreview
June 23, 2020
Apple Tree Partners (ATP) will exit its ownership stake in Corvidia Therapeutics, a precision cardiovascular therapeutics company, with Novo Nordisk’s acquisition of Corvidia.
Piramal Acquires Facility from G&W Laboratories contractpharma
June 23, 2020
Expands its offerings by adding solid oral dosage form capabilities in North America.
Piramal Pharma to acquire manufacturing facility from G&W Laboratories in the US expresspharma
June 22, 2020
Located in Sellersville, Pennsylvania, this facility will broaden the offering of Piramal Pharma Solutions (PPS) by adding solid oral dosage form capabilities (tablets and capsules) in North America.
Melinta to Acquire Tetraphase Pharmaceuticals americanpharmaceuticalreview
June 19, 2020
Melinta Therapeutics announced that on June 4, 2020, it entered into a definitive merger agreement with Tetraphase Pharmaceuticals.
Supernus Completes Acquisition of CNS Portfolio from US WorldMeds americanpharmaceuticalreview
June 19, 2020
Supernus Pharmaceuticals announced the closing of the acquisition of the CNS portfolio of US WorldMeds, a privately-held biopharmaceutical company.
The Creative Engagement Group buys Cormis pharmatimes
June 17, 2020
The Creative Engagement Group (TCEG), part of the Huntsworth healthcare and communications group, has bought Cormis, a strategic communications and training consultancy for the pharmaceutical industry.
Novo Nordisk to acquire Corvidia Therapeutics for $725m pharmaceutical-technology
June 15, 2020
Danish healthcare company Novo Nordisk has signed a definitive agreement to acquire US-based Corvidia Therapeutics, which develops and commercialises therapies for cardio-renal diseases, for an upfront payment of $725m.
Dr Reddy’s Laboratories completes acquisition of Wockhardt’s select business divisions expresspharma
June 11, 2020
The acquired divisions comprise a portfolio of 62 brands in multiple therapy areas such as respiratory, neurology, VMS, dermatology, gastroenterology, pain and vaccines.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page